ABSTRACT
OBJECTIVE: Pathology in both cortex and deep gray matter contribute to disability in multiple sclerosis (MS). We used the increased signal-to-noise ratio of 7-tesla (7T) MRI to visualize small lesions within the thalamus and to relate this to clinical information and cortical lesions. METHODS: We obtained 7T MRI scans on 34 MS cases and 15 healthy volunteers. Thalamic lesion number and volume were related to demographic data, clinical disability measures, and lesions in cortical gray matter. RESULTS: Thalamic lesions were found in 24/34 of MS cases. Two lesion subtypes were noted: discrete, ovoid lesions, and more diffuse lesional areas lining the periventricular surface. The number of thalamic lesions was greater in progressive MS compared to relapsing-remitting (mean ±SD, 10.7 ±0.7 vs. 3.0 ±0.7, respectively, p < 0.001). Thalamic lesion burden (count and volume) correlated with EDSS score and measures of cortical lesion burden, but not with white matter lesion burden or white matter volume. CONCLUSIONS: Using 7T MRI allows identification of thalamic lesions in MS, which are associated with disability, progressive disease, and cortical lesions. Thalamic lesion analysis may be a simpler, more rapid estimate of overall gray matter lesion burden in MS.
Subject(s)
Magnetic Resonance Imaging/methods , Multiple Sclerosis/pathology , Thalamus/pathology , Adult , Cerebral Cortex/pathology , Female , Gray Matter/pathology , Humans , Image Interpretation, Computer-Assisted , Male , Middle Aged , White Matter/pathologyABSTRACT
CASE: This report describes 2 cases of failed decellularized "off-the-shelf" Chondrofix (Zimmer Biomet) osteochondral allografts within a year after implantation in a 44-year-old man and a 50-year-old woman. CONCLUSION: Although it is a successful technique for cartilage repair, the use of osteochondral allograft transplantation has been limited by the availability of fresh grafts; therefore, decellularized osteochondral allografts recently have been developed. Physicians should be cautious when considering the use of these implants for the repair of articular cartilage lesions.
Subject(s)
Arthroplasty, Subchondral , Postoperative Complications/etiology , Adult , Allografts , Female , Humans , Male , Middle Aged , Postoperative Complications/surgery , ReoperationABSTRACT
PURPOSE: The advent of macular optical coherence tomography (OCT) segmentation has enabled the in vivo quantitative assessment of retinal axonal and neuronal subpopulations. Recent studies employing OCT in multiple sclerosis (MS) have utilized various manual macular segmentation approaches to quantify retinal layer thicknesses. We investigated whether measurements of retinal layers solely at the points of maximal macular thickness (point estimates) within the central macular B-scan are representative of the corresponding average layer thicknesses for the ganglion cell + inner plexiform (GCIP) layers, inner nuclear layer (INL), outer plexiform layer (OPL) and outer nuclear layer (ONL) in MS and healthy controls. Additionally, we examined the correlation of manual segmentation-derived measures of composite layers with average thickness measures derived from automated 3-D segmentation of the macular cube. MATERIALS AND METHODS: Spectral-domain OCT central macular B-scans of 52 MS patients and 30 healthy controls (HCs) were manually segmented. Average layer thicknesses and layer thicknesses at the points of maximal macular thickness were calculated. Macular cube scans were also segmented utilizing a fully automated 3-D segmentation algorithm. RESULTS: GCIP, INL and OPL maximal thicknesses derived from point estimates correlated well with the average thicknesses of these layers within the central macular B-scan, whereas the ONL maximal thickness did not correlate as strongly. Manual segmentation-derived point estimates and average thickness measures of the GCIP correlated excellently with corresponding automated segmentation-derived measures. MS patients had significantly decreased GCIP maximal and average thicknesses relative to HCs. ONL average thickness was significantly decreased in MS compared to HCs, but this was not true of the ONL maximal thickness. CONCLUSIONS: GCIP, INL and OPL maximal layer thicknesses may be used as surrogates to assess the gross structural integrity of these layers in MS, in a time-conservative fashion.
Subject(s)
Algorithms , Imaging, Three-Dimensional/methods , Multiple Sclerosis/pathology , Retinal Degeneration/pathology , Retinal Ganglion Cells/pathology , Tomography, Optical Coherence/methods , Adult , Axons/pathology , Female , Humans , Male , Middle Aged , Multiple Sclerosis/complications , Reproducibility of Results , Retinal Degeneration/etiologyABSTRACT
OBJECTIVE: To determine the effect of clinical and radiologic disease activity on the rate of thinning of the ganglion cell/inner plexiform (GCIP) layer and the retinal nerve fiber layer in patients with multiple sclerosis (MS) using optical coherence tomography (OCT). METHODS: One hundred sixty-four patients with MS and 59 healthy controls underwent spectral-domain OCT scans every 6 months for a mean follow-up period of 21.1 months. Baseline and annual contrast-enhanced brain MRIs were performed. Patients who developed optic neuritis during follow-up were excluded from analysis. RESULTS: Patients with the following features of disease activity during follow-up had faster rates of annualized GCIP thinning: relapses (42% faster, p = 0.007), new gadolinium-enhancing lesions (54% faster, p < 0.001), and new T2 lesions (36% faster, p = 0.02). Annual GCIP thinning was 37% faster in those with disability progression during follow-up, and 43% faster in those with disease duration <5 years vs >5 years (p = 0.003). Annual rates of GCIP thinning were highest in patients exhibiting combinations of new gadolinium-enhancing lesions, new T2 lesions, and disease duration <5 years (70% faster in patients with vs without all 3 characteristics, p < 0.001). CONCLUSIONS: MS patients with clinical and/or radiologic nonocular disease activity, particularly early in the disease course, exhibit accelerated GCIP thinning. Our findings suggest that retinal changes in MS reflect global CNS processes, and that OCT-derived GCIP thickness measures may have utility as an outcome measure for assessing neuroprotective agents, particularly in early, active MS.
Subject(s)
Multiple Sclerosis/pathology , Nerve Degeneration/pathology , Retinal Ganglion Cells/pathology , Retinal Neurons/pathology , Tomography, Optical Coherence/methods , Adult , Case-Control Studies , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged , Nerve Fibers/pathology , Neuroimaging/methods , Neuroimaging/statistics & numerical data , Tomography, Optical Coherence/statistics & numerical dataABSTRACT
OBJECTIVE: To determine the relationships between conventional and segmentation-derived optical coherence tomography (OCT) retinal layer thickness measures with intracranial volume (a surrogate of head size) and brain substructure volumes in multiple sclerosis (MS). DESIGN: Cross-sectional study. SETTING: Johns Hopkins University, Baltimore, Maryland. PARTICIPANTS: A total of 84 patients with MS and 24 healthy control subjects. MAIN OUTCOME MEASURES: High-definition spectral-domain OCT conventional and automated segmentation-derived discrete retinal layer thicknesses and 3-T magnetic resonance imaging brain substructure volumes. RESULTS: Peripapillary retinal nerve fiber layer as well as composite ganglion cell layer+inner plexiform layer thicknesses in the eyes of patients with MS without a history of optic neuritis were associated with cortical gray matter (P=.01 and P=.04, respectively) and caudate (P=.04 and P=.03, respectively) volumes. Inner nuclear layer thickness, also in eyes without a history of optic neuritis, was associated with fluid-attenuated inversion recovery lesion volume (P=.007) and inversely associated with normal-appearing white matter volume (P=.005) in relapsing-remitting MS. As intracranial volume was found to be related with several of the OCT measures in patients with MS and healthy control subjects and is already known to be associated with brain substructure volumes, all OCT-brain substructure relationships were adjusted for intracranial volume. CONCLUSIONS Retinal measures reflect global central nervous system pathology in multiple sclerosis, with thicknesses of discrete retinal layers each appearing to be associated with distinct central nervous system processes. Moreover, OCT measures appear to correlate with intracranial volume in patients with MS and healthy control subjects, an important unexpected factor unaccounted for in prior studies examining the relationships between peripapillary retinal nerve fiber layer thickness and brain substructure volumes.
Subject(s)
Axons/pathology , Central Nervous System/pathology , Multiple Sclerosis/pathology , Retina , Retinal Neurons/pathology , Adult , Caudate Nucleus/pathology , Cerebral Cortex/pathology , Cross-Sectional Studies , Female , Humans , Magnetic Resonance Imaging/instrumentation , Magnetic Resonance Imaging/methods , Male , Middle Aged , Retina/pathology , Tomography, Optical Coherence/instrumentation , Tomography, Optical Coherence/methodsABSTRACT
Macular optical coherence tomography (OCT) segmentation, enabling quantification of retinal axonal and neuronal subpopulations, may help elucidate the neuroretinal pathobiology of multiple sclerosis (MS). This study aimed to determine the agreement, reproducibility, and visual correlations of retinal layer thicknesses measured by different OCT segmentation techniques, on two spectral-domain OCT devices. Macular scans of 52 MS patients and 30 healthy controls from Spectralis OCT and Cirrus HD-OCT were segmented using fully manual (Spectralis), computer-aided manual (Spectralis and Cirrus), and fully automated (Cirrus) segmentation techniques. Letter acuity was recorded. Bland-Altman analyses revealed low mean differences across OCT segmentation techniques on both devices for ganglion cell + inner plexiform layers (GCIP; 0.76-2.43 µm), inner nuclear + outer plexiform layers (INL + OPL; 0.36-1.04 µm), and outer nuclear layers including photoreceptor segment (ONL + PR; 1.29-3.52 µm) thicknesses. Limits of agreement for GCIP and ONL + PR thicknesses were narrow. Results of fully manual and computer-aided manual segmentation were comparable to those of fully automated segmentation. MS patients demonstrated macular RNFL, GCIP, and ONL + PR thinning compared to healthy controls across OCT segmentation techniques, irrespective of device (p < 0.03 for all). Low-contrast letter acuity in MS correlated significantly and more strongly with GCIP than peripapillary RNFL thicknesses, regardless of the segmentation method or device. GCIP and ONL + PR thicknesses, measured by different OCT devices and segmentation techniques, are reproducible and agree at the individual and cohort levels. GCIP thinning in MS correlates with visual dysfunction. Significant ONL + PR thinning, detectable across OCT segmentation techniques and devices, strongly supports ONL pathology in MS. Fully automated, fully manual and computer-assisted manual OCT segmentation techniques compare closely, highlighting the utility of accurate and time-efficient automated segmentation outcomes in MS clinical trials.
Subject(s)
Image Interpretation, Computer-Assisted/methods , Multiple Sclerosis/pathology , Retinal Neurons/pathology , Tomography, Optical Coherence/methods , Adult , Aged , Female , Humans , Male , Middle Aged , Young AdultABSTRACT
BACKGROUND: Microcystic macular oedema (MMO) of the retinal inner nuclear layer (INL) has been identified in patients with multiple sclerosis (MS) by use of optical coherence tomography (OCT). We aimed to determine whether MMO of the INL, and increased thickness of the INL are associated with disease activity or disability progression. METHODS: This retrospective study was done at the Johns Hopkins Hospital (Baltimore, MD, USA), between September, 2008, and March, 2012. Patients with MS and healthy controls underwent serial OCT scans and clinical assessments including visual function. OCT scanning, including automated intraretinal layer segmentation, yielded thicknesses of the retinal nerve fibre layer, the ganglion cell layer plus inner plexiform layer, the INL plus outer plexiform layer (the combined thickness of these layers was used as a surrogate measure of INL thickness), and the outer nuclear layer. Patients with MS also underwent annual brain MRI scans. Disability scores were compared with the Wilcoxon rank-sum test. Mixed-effects linear regression was used to compare OCT measures and letter-acuity scores. Logistic regression was used to examine the relations of baseline OCT thicknesses with clinical and radiological parameters. FINDINGS: 164 patients with MS and 60 healthy controls were assessed. Mean follow-up was 25·8 months (SD 9·1) for patients with MS and 22·4 months (11·4) for healthy controls. Ten (6%) patients with MS had MMO during at least one study visit; MMO was visible at baseline in four of these patients. Healthy controls did not have MMO. Patients with MS and MMO had higher baseline MS severity scores (median 5·93 [range 2·44-8·91]) than those who did not have MMO at any time during the study (151 patients; 3·81 [0·13-9·47]; p=0·032), although expanded disability status scale (EDSS) scores were not significantly different (5·2 [1·0-6·5] for patients with MS and MMO vs 2·5 [0·0-8·0] for those without MMO; p=0·097). The eyes of patients with MS and MMO (12 eyes) versus those without MMO (302 eyes) had lower letter-acuity scores (100% contrast, p=0·017; 2·5% contrast, p=0·031; 1·25% contrast, p=0·014), and increased INL thicknesses (p=0·003) at baseline. Increased baseline INL thickness in patients with MS was associated with the development of contrast-enhancing lesions (p=0·007), new T2 lesions (p=0·015), EDSS progression (p=0·034), and relapses in patients with relapsing-remitting MS (p=0·008) during the study. MMO was not associated with disease activity during follow-up. INTERPRETATION: Increased INL thickness on OCT is associated with disease activity in MS. If this finding is confirmed, INL thickness could be a useful predictor of disease progression in patients with MS. FUNDING: National Multiple Sclerosis Society, National Eye Institute, Braxton Debbie Angela Dillon and Skip Donor Advisor Fund.